ID

42571

Description

Continuous Glucose Monitoring in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00529815

Link

https://clinicaltrials.gov/show/NCT00529815

Keywords

Versions (2)
  1. 3/2/17 3/2/17 -
  2. 9/2/21 9/2/21 -
Uploaded on

September 2, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes Mellitus Type 2 NCT00529815

English

Eligibility Diabetes Mellitus Type 2 NCT00529815

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. age 18 or older.
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
2. known type 2 diabetes for at least 3 months
Description

type 2 diabetes

Data type

boolean

Alias
UMLS CUI [1]
C0011860
3. diet controlled, on oral therapy, on basal insulin (e.g. glargine), or on oral therapy and a basal insulin
Description

Dietary control | Oral hypoglycemic | Basal insulin | Combined Modality Therapy

Data type

boolean

Alias
UMLS CUI [1]
C0743195
UMLS CUI [2]
C0359086
UMLS CUI [3]
C0650607
UMLS CUI [4]
C0009429
4. a1c levels between 7% and 12%.
Description

hba1c

Data type

boolean

Alias
UMLS CUI [1]
C0019018
5. able to independently measure and read finger stick blood glucose levels with the accu-chek aviva glucometer and the dexcom continuous glucose monitoring device (dexcom dts-7).
Description

Blood Glucose Self-Monitoring; Glucose measurement by monitoring device

Data type

boolean

Alias
UMLS CUI [1,1]
C0005803
UMLS CUI [1,2]
C0202048
6. subjects will have attended a american diabetes association recognized diabetes self-management education (dsme) program at one of the wrhcs military treatment facilities (mtfs) within the past five years.
Description

diabetes self-management education

Data type

boolean

Alias
UMLS CUI [1]
C3698325
7. willing to avoid or minimize use of acetaminophen (tylenol) and all acetaminophen-containing products such as most over-the-counter (otc) medications during the study period (appendix 5)..
Description

avoid or minimize use of acetaminophen

Data type

boolean

Alias
UMLS CUI [1,1]
C0000970
UMLS CUI [1,2]
C2096017
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. female subjects who are pregnant, lactating, planning to become pregnant, or without a safe contraceptive method.
Description

pregnancy, breast feeding, contraceptive methods

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0700589
2. a1c levels are less than 7 or greater than 12.
Description

hba1c

Data type

boolean

Alias
UMLS CUI [1]
C0019018
3. subjects who are taking glucocorticoids, amphetamines, anabolic, or weight-reducing agents during the course of the study.
Description

Steroid therapy | Amphetamines | Anabolic steroids | Pharmaceutical Preparations; Weight decreased

Data type

boolean

Alias
UMLS CUI [1]
C0149783
UMLS CUI [2]
C0002667
UMLS CUI [3]
C0002845
UMLS CUI [4,1]
C0013227
UMLS CUI [4,2]
C1262477
Back to the top of the page

Similar models

Eligibility Diabetes Mellitus Type 2 NCT00529815

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
1. age 18 or older.
boolean
C0001779 (UMLS CUI [1])
type 2 diabetes
Item
2. known type 2 diabetes for at least 3 months
boolean
C0011860 (UMLS CUI [1])
Dietary control | Oral hypoglycemic | Basal insulin | Combined Modality Therapy
Item
3. diet controlled, on oral therapy, on basal insulin (e.g. glargine), or on oral therapy and a basal insulin
boolean
C0743195 (UMLS CUI [1])
C0359086 (UMLS CUI [2])
C0650607 (UMLS CUI [3])
C0009429 (UMLS CUI [4])
hba1c
Item
4. a1c levels between 7% and 12%.
boolean
C0019018 (UMLS CUI [1])
Blood Glucose Self-Monitoring; Glucose measurement by monitoring device
Item
5. able to independently measure and read finger stick blood glucose levels with the accu-chek aviva glucometer and the dexcom continuous glucose monitoring device (dexcom dts-7).
boolean
C0005803 (UMLS CUI [1,1])
C0202048 (UMLS CUI [1,2])
diabetes self-management education
Item
6. subjects will have attended a american diabetes association recognized diabetes self-management education (dsme) program at one of the wrhcs military treatment facilities (mtfs) within the past five years.
boolean
C3698325 (UMLS CUI [1])
avoid or minimize use of acetaminophen
Item
7. willing to avoid or minimize use of acetaminophen (tylenol) and all acetaminophen-containing products such as most over-the-counter (otc) medications during the study period (appendix 5)..
boolean
C0000970 (UMLS CUI [1,1])
C2096017 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
pregnancy, breast feeding, contraceptive methods
Item
1. female subjects who are pregnant, lactating, planning to become pregnant, or without a safe contraceptive method.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
hba1c
Item
2. a1c levels are less than 7 or greater than 12.
boolean
C0019018 (UMLS CUI [1])
Steroid therapy | Amphetamines | Anabolic steroids | Pharmaceutical Preparations; Weight decreased
Item
3. subjects who are taking glucocorticoids, amphetamines, anabolic, or weight-reducing agents during the course of the study.
boolean
C0149783 (UMLS CUI [1])
C0002667 (UMLS CUI [2])
C0002845 (UMLS CUI [3])
C0013227 (UMLS CUI [4,1])
C1262477 (UMLS CUI [4,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial